Details of the Drug

General Information of Drug (ID: DMBLID9)

Drug Name

N-acetylcysteine

Synonyms

N-Acetyl-L-cysteine; acetylcysteine; 616-91-1; N-Acetylcysteine; mercapturic acid; Acetadote; L-Acetylcysteine; Broncholysin; Fluimucil; Mucomyst; N-Acetyl-cysteine; Parvolex; Fluprowit; Acetein; Airbron; Fabrol; Flumucetin; Mucosolvin; Fluimucetin; Mucosil; Brunac; Fluimicil Infantil; Acetylcysteinum; Acetilcisteina; Respaire; Mucofilin; Lysomucil; Exomuc; Inspir; Ac-Cys-OH; Mucolyticum Lappe; Mucolytikum Lappe; N-Acetyl cysteine; Mucolyticum; LNAC; N-Acetyl-3-mercaptoalanine; N-Acetyl-L-(+)-cysteine; Neo-fluimucil; NAC-TB; Mucolyticum-Lappe; (R; Acetylcysteine

Indication

Disease Entry	ICD 11	Status	REF
Cystic fibrosis	CA25	Approved	[1]
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 2	[2]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C5H9NO3S
Canonical SMILES: CC(=O)NC(CS)C(=O)O
InChI: 1S/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-/m0/s1
InChIKey: PWKSKIMOESPYIA-BYPYZUCNSA-N

Cross-matching ID

PubChem CID: 12035
ChEBI ID: CHEBI:28939
CAS Number: 616-91-1
TTD ID: D05NEK

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (ANDA) 074037.
2	ClinicalTrials.gov (NCT04279197) Treatment of Pulmonary Fibrosis Due to 2019-nCoV Pneumonia With Fuzheng Huayu. U.S. National Institutes of Health.